Research database to help promote pharma/academic collaborations
The ABPI has developed a new tool to help build research relationships between the pharmaceutical industry and UK academics.
List view / Grid view
The ABPI has developed a new tool to help build research relationships between the pharmaceutical industry and UK academics.
A new diagnostic will allow men to bypass painful biopsies to test for aggressive prostate cancer.
Researchers have pioneered a technique which uses florescent imaging to track the actions of key enzymes in cancer, genetic disorders and kidney disease.
Researchers at The Australian National University (ANU) are working on a new treatment for an aggressive type of leukaemia that outperforms standard chemotherapies.
Sophia Genetics injects artificial intelligence in liquid biopsies to accelerate early detection of cancer and monitor treatments’ effectiveness.
A clearer picture of how the classic diabetes medication metformin works has emerged.
SOPHiA AI demystifies the secrets of the exome, home to 85% of disease-causing genetic variants. Clinicians can now get highly accurate results to diagnose patients for rare hereditary disorders.
Antibodies are able to activate human nerve cells within milliseconds and hence modify their function.
Lyme disease – an infection contracted from the bite of an infected tick– is an important emerging disease in the UK, and is increasing in incidence in people in the UK and large parts of Europe and North America.
New diagnoses for two types of skin cancer increased in recent years, according to a Mayo Clinic-led team of researchers.
A new test of blood clot strength has the potential to identify patients who are most in need of a substantial blood transfusion.
Genetic alterations that can be modulated by stress have been identified in children at high risk for bipolar disorder, according to a new study...
A highly sensitive method that can detect even the earlier stages of colorectal cancer has been developed by researchers in Japan.
Traditional toxicological investigations performed on animals (in vivo) are expensive, time-consuming and may cause animal suffering.
Kidney cancer rates have increased by 40% over the last 10 years in the UK, and the rise is expected to continue. An estimated 20,000 kidney cancer cases have been caused by obesity over the last decade in England, according to new figures from Cancer Research UK.